Jenscare is a medical device company developing world leading mini-invasive, catheter base tricuspid valve replacement to treat tricuspid valve regurgitation. The company is found by structural heart engineer experts and China’s renown surgeons. Jenscare’s tricuspid valve have been placed on more than 40 patients which makes it the leading company globally. The company has also developed transcatheter aortic valve replacement, transcatheter tricuspid valve repair product and transcatheter mitral valve repair product. The company won a number of important innovation awards including 2nd place for China Medical Device Innovation competition award and 4th place in TCT Shark Tank competition in 2019.